With the analysis among 68 patents, we discovered top 40 key players by total patent application. SciClone Pharmaceuticals LLC, Hybio Pharmaceutical Co.. Ltd., Suzhou Thery Pharmaceutical, Inc. are dominant in this area. They take 33.82% of the total patent filing.
California, United States
Patent: 12
Guangdong Sheng, China
Patent: 8
Jiangsu Sheng, China
Patent: 3
Henan Sheng, China
Patent: 3
Henan Sheng, China
Patent: 3
Zhejiang Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Sichuan Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 2
California, United States
Patent: 1
No data, please try another search term
With the analysis among related 19 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Suzhou Thery Pharmaceutical, Inc., Kaifeng Mingren Pharmaceutical Co., Ltd., Hybio Pharmaceutical Co.. Ltd. take 36.84% of patent filing during this period.
Jiangsu Sheng, China
Patent: 3
Henan Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Henan Sheng, China
Patent: 2
Heilongjiang Sheng, China
Patent: 1
Sichuan Sheng, China
Patent: 1
Guangdong Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among related 19 patents in last 5 years, we discover 9 new entrants. Suzhou Thery Pharmaceutical, Inc., Suzhou RxD Biopharmaceutical Co., Ltd, Jiangsu Genscript Biotech Co., Ltd. are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 3
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 1
undefined undefined
Patent: 1
Heilongjiang Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Guangdong Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
No data, please try another search term